How did ANAB's revenue surge in Q4 2024 impact its annual performance?

AnaptysBio (ANAB) experienced a notable surge in revenue during Q4 2024, with a year-over-year growth rate of 3.79% in that quarter. This positive performance had a significant impact on the company's annual revenue, resulting in a cumulative year-over-year growth rate of 4.32% for the full year of 2024. 1. **Q4 2024 Performance**: In Q4 2024, ANAB's revenue reached $43.11 million, with a substantial increase from the previous year's revenue of $9.01 million in the same quarter. |code|Ticker|Name|Date|Total Revenue YoY|Total Revenue|market_code| |---|---|---|---|---|---|---| |ANAB|ANAB.O|AnaptysBio|2024 Q1|422.48908296943233|7179000|185| |ANAB|ANAB.O|AnaptysBio|2024 Q2|217.08092485549133|1.0971E7|185| |ANAB|ANAB.O|AnaptysBio|2024 Q3|804.671488848704|3.0017E7|185| |ANAB|ANAB.O|AnaptysBio|2024 Q4|378.76735147140477|4.3113E7|185| 2. **Annual Performance Impact**: The strong revenue growth in Q4 2024 contributed significantly to ANAB's annual revenue, which totaled $91.28 million for the year 2024, reflecting a 4.32% increase from the previous year's revenue. |code|Ticker|Name|Date|Total Revenue YoY|market_code| |---|---|---|---|---|---| |ANAB|ANAB.O|AnaptysBio|2024 Q1|422.48908296943233|185| |ANAB|ANAB.O|AnaptysBio|2024 Q2|217.08092485549133|185| |ANAB|ANAB.O|AnaptysBio|2024 Q3|804.671488848704|185| |ANAB|ANAB.O|AnaptysBio|2024 Q4|378.76735147140477|185| The surge in Q4 2024 revenue not only boosted ANAB's quarterly performance but also had a positive cumulative effect on the company's annual revenue, indicating a strong financial performance for the year.